XML 85 R55.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Capital Management (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2018
Corporate Information And Statement Of IFRS Compliance [Abstract] |
Schedule of Total Capital | For regulatory reporting purposes under the LICAT framework, there were further adjustments, including goodwill, non-life investments, and others as was prescribed by OSFI, to the total capital figure presented in the table below:
As at December 31, | 2018 |  | 2017 |
Subordinated debt |  | $ | 3,039 |  |  | $ | 3,437 |
Innovative capital instruments(1) |  | 699 |  |  | 699 |
Equity: |  |  |  |
Participating policyholders' equity |  | 864 |  |  | 650 |
Preferred shareholders' equity |  | 2,257 |  |  | 2,257 |
Common shareholders' equity |  | 21,449 |  |  | 20,064 |
Total capital |  | $ | 28,308 |  |  | $ | 27,107 |
(1) Innovative capital instruments are SLEECS issued by the SL Capital Trusts (Note 13). The SL Capital Trusts are not consolidated by us.

X
- Definition Corporate Information And Statement Of IFRS Compliance [Abstract] + References No definition available. + Details
Name: | slf_CorporateInformationAndStatementOfIFRSComplianceAbstract
Namespace Prefix: | slf_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure Of Total Capital [Table Text Block] + References No definition available. + Details
Name: | slf_DisclosureOfTotalCapitalTableTextBlock
Namespace Prefix: | slf_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration